Cite
Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial.
MLA
Cottereau, Anne-Ségolène, et al. “Prognostic Value of Baseline Metabolic Tumor Volume in Early-Stage Hodgkin Lymphoma in the Standard Arm of the H10 Trial.” Blood, vol. 131, no. 13, Mar. 2018, pp. 1456–63. EBSCOhost, https://doi.org/10.1182/blood-2017-07-795476.
APA
Cottereau, A.-S., Versari, A., Loft, A., Casasnovas, O., Bellei, M., Ricci, R., Bardet, S., Castagnoli, A., Brice, P., Raemaekers, J., Deau, B., Fortpied, C., Raveloarivahy, T., Van Zele, E., Chartier, L., Vander Borght, T., Federico, M., Hutchings, M., Ricardi, U., & Andre, M. (2018). Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial. Blood, 131(13), 1456–1463. https://doi.org/10.1182/blood-2017-07-795476
Chicago
Cottereau, Anne-Ségolène, Annibale Versari, Annika Loft, Olivier Casasnovas, Monica Bellei, Romain Ricci, Stéphane Bardet, et al. 2018. “Prognostic Value of Baseline Metabolic Tumor Volume in Early-Stage Hodgkin Lymphoma in the Standard Arm of the H10 Trial.” Blood 131 (13): 1456–63. doi:10.1182/blood-2017-07-795476.